141 related articles for article (PubMed ID: 22127998)
1. Concurrent chemoradiotherapy for locoregionally advanced salivary gland malignancies.
Rosenberg L; Weissler M; Hayes DN; Shockley W; Zanation A; Rosenman J; Chera B
Head Neck; 2012 Jun; 34(6):872-6. PubMed ID: 22127998
[TBL] [Abstract][Full Text] [Related]
2. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.
Schoenfeld JD; Sher DJ; Norris CM; Haddad RI; Posner MR; Balboni TA; Tishler RB
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):308-14. PubMed ID: 21075557
[TBL] [Abstract][Full Text] [Related]
3. Chemoreirradiation for recurrent salivary gland malignancies.
Pederson AW; Haraf DJ; Blair EA; Stenson KM; Witt ME; Vokes EE; Salama JK
Radiother Oncol; 2010 Jun; 95(3):308-11. PubMed ID: 20385414
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma.
Tanvetyanon T; Qin D; Padhya T; McCaffrey J; Zhu W; Boulware D; DeConti R; Trotti A
Arch Otolaryngol Head Neck Surg; 2009 Jul; 135(7):687-92. PubMed ID: 19620591
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in patients with minor salivary gland carcinoma of the oral cavity and oropharynx.
Carrillo JF; Maldonado F; Carrillo LC; Ramirez-Ortega MC; Pizano JG; Melo C; Chanona JG; Luna-Ortiz K; Ocaña LF
Head Neck; 2011 Oct; 33(10):1406-12. PubMed ID: 21928413
[TBL] [Abstract][Full Text] [Related]
6. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.
Porceddu SV; Campbell B; Rischin D; Corry J; Weih L; Guerrieri M; Grossi M; Peters LJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):365-73. PubMed ID: 15380568
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel and carboplatin for recurrent salivary gland malignancies.
Airoldi M; Fornari G; Pedani F; Marchionatti S; Gabriele P; Succo G; Bumma C
Anticancer Res; 2000; 20(5C):3781-3. PubMed ID: 11268454
[TBL] [Abstract][Full Text] [Related]
8. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
Malone JP; Stephens JA; Grecula JC; Rhoades CA; Ghaheri BA; Schuller DE
Head Neck; 2004 Jul; 26(7):561-72. PubMed ID: 15229898
[TBL] [Abstract][Full Text] [Related]
9. Update and perspectives on non-surgical treatment of salivary gland malignancies.
Airoldi M; Cortesina G; Giordano C; Pedani F; Cavalot A; Marcato P; Beatrice F; Bumma C
Acta Otorhinolaryngol Ital; 2003 Oct; 23(5):368-76. PubMed ID: 15108487
[TBL] [Abstract][Full Text] [Related]
10. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.
Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
12. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
[TBL] [Abstract][Full Text] [Related]
13. Recurrent salivary gland carcinomas treated by surgery with or without intraoperative radiation therapy.
Chen AM; Garcia J; Bucci MK; Chan AS; Kaplan MJ; Singer MI; Phillips TL
Head Neck; 2008 Jan; 30(1):2-9. PubMed ID: 17828788
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy of carboplatin and paclitaxel for advanced/metastatic salivary gland carcinoma patients: differences in responses by different pathological diagnoses.
Nakano K; Sato Y; Sasaki T; Shimbashi W; Fukushima H; Yonekawa H; Mitani H; Kawabata K; Takahashi S
Acta Otolaryngol; 2016 Sep; 136(9):948-51. PubMed ID: 27094013
[TBL] [Abstract][Full Text] [Related]
15. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
[TBL] [Abstract][Full Text] [Related]
16. Concurrent chemoradiotherapy with cyclophosphamide, pirarubicin, and cisplatin for patients with locally advanced salivary gland carcinoma.
Katori H; Tsukuda M
Acta Otolaryngol; 2006 Dec; 126(12):1309-14. PubMed ID: 17101593
[TBL] [Abstract][Full Text] [Related]
17. Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial.
Pöttgen C; Eberhardt WE; Gauler T; Krbek T; Berkovic K; Jawad JA; Korfee S; Teschler H; Stamatis G; Stuschke M
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):809-15. PubMed ID: 19427744
[TBL] [Abstract][Full Text] [Related]
18. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
Parker K; Gallop-Evans E; Hanna L; Adams M
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high-risk salivary gland carcinomas.
Mifsud MJ; Tanvetyanon T; Mccaffrey JC; Otto KJ; Padhya TA; Kish J; Trotti AM; Harrison LB; Caudell JJ
Head Neck; 2016 Nov; 38(11):1628-1633. PubMed ID: 27098984
[TBL] [Abstract][Full Text] [Related]
20. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]